In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GPC Biotech Inc.

Division of Agennix Inc./GPC Biotech AG

Latest From GPC Biotech Inc.

GPC Looks to Nasdaq for the Best of Both Worlds

A late-June listing may help Germany's GPC Biotech AG attract investor interest and it certainly reinforces the firm's increasing Americanization. Yet the performance of lead candidate satraplatin remains the strongest determinant of GPC's valuation and near-term success.
BioPharmaceutical Strategy

GPC Leads German Dealmaking

Germany's GPC Biotech AG has already signed two deals with pharmaceutical companies this year. Both partners are fellow Germans, but neither deal would have happened had GPC not chosen to make itself international through acquiring privately held US oncology company Mitotix Inc. last March.

Validated Target Discovery: Letting Nature Do The Work

Genomics has yielded more potential drug targets than anybody knows what to do with. Several start-ups are looking to streamline discovery by simultaneously identifying and validating targets.
BioPharmaceutical Research and Development Strategies

The Opportunity in Cancer: Goldberg's Variation

Prostate cancer will be the focus of ProQuest Investments LP, a new venture fund founded by Jeremy Goldberg. With investors the Ann and Robert H. Lurie Foundation of Chicago, Alza Corp., and high net worth individuals, including Michael Milken, ProQuest has raised $40.5 million in its first closing.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Mitotix Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Agennix Inc.
  • Senior Management
  • William Helman, Chmn.
    James Melanson, VP, Fin. & Admin.
    Arthur Kluge, PhD, VP, Drug Discovery
    Thomas Needman, VP, Bus. Dev.
    Muzammil M Mansuri, PhD, EVP, Research
  • Contact Info
  • GPC Biotech Inc.
    Phone: (781) 890-9007
    610 Lincoln St.
    Waltham, MA 02451